Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo A, Bougouma EC, Palacpac NMQ, Houard S, Nebie I, Sawadogo J, Berges GD, Soulama I, Diarra A, Hien D, Ouedraogo AZ, Konaté AT, Kouanda S, Myoui A, Ezoe S, Ishii KJ, Sato T, D'Alessio F, Leroy O, Tiono AB, Cousens S, Horii T, Sirima SB.
Ouédraogo A, et al. Among authors: nebie i.
Front Immunol. 2023 Oct 16;14:1267372. doi: 10.3389/fimmu.2023.1267372. eCollection 2023.
Front Immunol. 2023.
PMID: 37908361
Free PMC article.
Clinical Trial.